Budesonide Market in India, Industry Outlook and Forecast 2024-2030

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

This report contains market size and forecasts of Budesonide in India, highlights the following information:

Sales of Budesonide in India: Value 2019 VS 2023 VS 2030, ($ millions)

Sales of Budesonide in India: Volume 2019 VS 2023 VS 2030, (M Units)

Sales of Budesonide in India: Revenue Market Share by Company, 2019-2024

Sales of Budesonide in India: Volume Market Share by Company, 2019-2024

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Budesonide will continue to grow rapidly in the future.

The global Budesonide market size was valued at 8203 million in 2023 and is forecast to a readjusted size of US$ 10250 million by 2030, with a CAGR of 3.2% during the forecast period 2024-2030.While the India Budesonide market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. India will account for % percent of Budesonide's global value in 2030, from % in 2023.

Our research team has surveyed the Budesonide manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, Value, demand, price change, product matrix, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

India Budesonide Market, By Type, 2019-2024, 2025-2030 ($ Millions) & (M Units)

India Budesonide Market Segment Percentages, By Type, 2023 (%)

Injectable Suspension

Aerosols

Inhalation Powder

Tablet and Capsule

India Budesonide Market, By Application, 2019-2024, 2025-2030 ($ Millions) & (M Units)

India Budesonide Market Segment Percentages, By Application, 2023 (%)

Respiratory Disease Treatment

Nose Disease Treatment

Inflammatory Bowel Disease Treatment

Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Budesonide revenues in India market, 2019-2024 (Estimated), ($ millions)

Key companies Budesonide sales in India market, 2019-2024 (Estimated), (M Units)

Further, the report presents profiles of competitors in the market, key players include:

AstraZeneca

Teva

Mylan

Sandoz

Cosmo Pharmaceuticals

Salix

Chiesi Farmaceutici

Orion Corporation

Cipla

Synmosa Biopharma

Lunan Better Pharma

Shanghai Sine Promod